Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thrombocytosis | 1 | 2016 | 89 | 0.540 |
Why?
|
Polycythemia | 1 | 2016 | 124 | 0.510 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2024 | 5315 | 0.410 |
Why?
|
Ribonuclease III | 3 | 2013 | 279 | 0.390 |
Why?
|
Aphasia | 1 | 2013 | 192 | 0.370 |
Why?
|
DEAD-box RNA Helicases | 3 | 2013 | 384 | 0.370 |
Why?
|
Carcinoma, Transitional Cell | 3 | 2024 | 783 | 0.360 |
Why?
|
Lung Neoplasms | 5 | 2024 | 13382 | 0.310 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2013 | 513 | 0.310 |
Why?
|
MicroRNAs | 4 | 2013 | 3816 | 0.230 |
Why?
|
Mesenchymal Stem Cells | 2 | 2013 | 1642 | 0.200 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2827 | 0.200 |
Why?
|
Sarcoma | 1 | 2012 | 1801 | 0.180 |
Why?
|
Primary Health Care | 1 | 2016 | 4686 | 0.170 |
Why?
|
Cell Proliferation | 1 | 2012 | 10448 | 0.130 |
Why?
|
Hematologic Tests | 1 | 2016 | 239 | 0.130 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 1962 | 0.120 |
Why?
|
Urologic Neoplasms | 1 | 2019 | 314 | 0.120 |
Why?
|
Autoantibodies | 1 | 2024 | 2116 | 0.120 |
Why?
|
RNA | 2 | 2022 | 2726 | 0.120 |
Why?
|
Nuclear Receptor Subfamily 6, Group A, Member 1 | 1 | 2013 | 3 | 0.110 |
Why?
|
Blotting, Northern | 2 | 2012 | 1545 | 0.110 |
Why?
|
Stroke | 1 | 2013 | 9758 | 0.090 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2022 | 2223 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2024 | 5305 | 0.080 |
Why?
|
Multigene Family | 1 | 2011 | 1076 | 0.080 |
Why?
|
Tamoxifen | 1 | 2012 | 965 | 0.070 |
Why?
|
Software | 1 | 2021 | 4434 | 0.070 |
Why?
|
TRPV Cation Channels | 1 | 2009 | 244 | 0.070 |
Why?
|
Mice, Knockout | 4 | 2024 | 14416 | 0.070 |
Why?
|
Embryonic Stem Cells | 2 | 2011 | 1263 | 0.070 |
Why?
|
Genomics | 1 | 2023 | 5821 | 0.070 |
Why?
|
Green Fluorescent Proteins | 1 | 2012 | 2065 | 0.070 |
Why?
|
Disease Management | 1 | 2016 | 2508 | 0.060 |
Why?
|
Cell Polarity | 1 | 2009 | 636 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4575 | 0.060 |
Why?
|
Blotting, Western | 1 | 2012 | 5035 | 0.060 |
Why?
|
MutS Homolog 2 Protein | 1 | 2024 | 197 | 0.060 |
Why?
|
Mechanotransduction, Cellular | 1 | 2009 | 529 | 0.060 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2012 | 1520 | 0.060 |
Why?
|
Cells, Cultured | 4 | 2012 | 18965 | 0.060 |
Why?
|
Sequence Analysis, RNA | 2 | 2022 | 2020 | 0.060 |
Why?
|
Mice | 6 | 2024 | 81533 | 0.050 |
Why?
|
Genome | 1 | 2011 | 1740 | 0.050 |
Why?
|
Melanoma | 1 | 2022 | 5709 | 0.050 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2024 | 171 | 0.050 |
Why?
|
Fibroblasts | 1 | 2013 | 4141 | 0.050 |
Why?
|
Cell Line, Tumor | 2 | 2024 | 16986 | 0.050 |
Why?
|
Gene Expression Profiling | 3 | 2012 | 9420 | 0.050 |
Why?
|
Flow Cytometry | 1 | 2012 | 5869 | 0.050 |
Why?
|
Humans | 15 | 2024 | 761572 | 0.050 |
Why?
|
Antigens, Neoplasm | 2 | 2024 | 1993 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12975 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 22172 | 0.040 |
Why?
|
Disease Progression | 1 | 2016 | 13510 | 0.040 |
Why?
|
Mice, Transgenic | 1 | 2012 | 9541 | 0.040 |
Why?
|
Quality Control | 1 | 2021 | 832 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2013 | 11904 | 0.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 899 | 0.040 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2022 | 1092 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2009 | 3548 | 0.030 |
Why?
|
Animals | 7 | 2024 | 168467 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2012 | 8552 | 0.030 |
Why?
|
Prognosis | 1 | 2016 | 29629 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20571 | 0.030 |
Why?
|
Gene Deletion | 2 | 2013 | 2665 | 0.030 |
Why?
|
Caspase 2 | 1 | 2011 | 26 | 0.020 |
Why?
|
RNA Interference | 2 | 2011 | 2832 | 0.020 |
Why?
|
Cell Survival | 2 | 2011 | 5791 | 0.020 |
Why?
|
Pregnancy | 1 | 2013 | 29876 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2011 | 1058 | 0.020 |
Why?
|
Base Sequence | 2 | 2011 | 12441 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2013 | 802 | 0.020 |
Why?
|
Gamma Rays | 1 | 2011 | 318 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3877 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 3639 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2011 | 519 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6815 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4580 | 0.020 |
Why?
|
Mutation | 2 | 2022 | 30054 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2011 | 678 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2024 | 7858 | 0.020 |
Why?
|
Female | 4 | 2022 | 392686 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2011 | 1135 | 0.020 |
Why?
|
Capillaries | 1 | 2009 | 755 | 0.020 |
Why?
|
Fibronectins | 1 | 2009 | 723 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 16592 | 0.020 |
Why?
|
Aged | 3 | 2024 | 169310 | 0.020 |
Why?
|
Doxorubicin | 1 | 2011 | 2224 | 0.010 |
Why?
|
Adult | 2 | 2022 | 221203 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 2009 | 1674 | 0.010 |
Why?
|
Phylogeny | 1 | 2011 | 2811 | 0.010 |
Why?
|
Male | 4 | 2024 | 360842 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2023 | 18253 | 0.010 |
Why?
|
Cattle | 1 | 2009 | 3849 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2011 | 4615 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3778 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15266 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2009 | 3088 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2013 | 3612 | 0.010 |
Why?
|
DNA Damage | 1 | 2011 | 2449 | 0.010 |
Why?
|
Protein Binding | 1 | 2013 | 9353 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2011 | 2986 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2009 | 3733 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2009 | 3430 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2009 | 2865 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 41493 | 0.010 |
Why?
|
Cell Line | 1 | 2013 | 15601 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2011 | 17635 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2022 | 58986 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5799 | 0.010 |
Why?
|
Young Adult | 1 | 2022 | 59255 | 0.010 |
Why?
|
Apoptosis | 1 | 2011 | 9489 | 0.010 |
Why?
|
Transcription Factors | 1 | 2011 | 12129 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 80646 | 0.010 |
Why?
|
Middle Aged | 1 | 2022 | 220920 | 0.000 |
Why?
|
Signal Transduction | 1 | 2011 | 23447 | 0.000 |
Why?
|
Concepts
(117)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(42)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_